Your Article Summary
Patient experience with a new teriparatide delivery device
Current Medical Research and Opinion, 08/10/09
Dore RK et al. – Patients found the new teriparatide delivery device easy to use and Current Users preferred the new delivery device over the original device.
Robin K. Dore, 08/11/09
| In my experience, the use of teriparatide in the past was limited by the former device. As stated in the article, many patients were unable to comprehend the complex instructions, were unable to hold the pen or were unable to see the arrow in the window on the pen. Given the results of this study, hopefully more patients who are candidates for teriparatide therapy will be able to use the new device. |
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
New England Journal of Medicine, 11/20/09
Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
JAMA, 11/25/09
Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
Abbott, 11/16/09
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
AstraZeneca submits US New Drug Application for ticagrelor, an investigational antiplatelet agent
AstraZeneca, 11/23/09
FDA Grants Emergency Use Authorization of the Prodesse ProFlu-ST(TM)
Gen-Probe, 10/30/09
Gyrus PlasmaKinetic bipolar coagulation device for liver resection
Australian and New Zealand Journal of Surgery, 11/13/09
Article Search
Sponsor


See Latest Articles


